| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |